期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | MOLECULAR AND CELLULAR NEUROSCIENCE LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 5.2 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | MOL CELL NEUROSCI | ||||||||||||||||||||||||
ISSN | 1044-7431 | ||||||||||||||||||||||||
E-ISSN | 1095-9327 | ||||||||||||||||||||||||
h-index | 127 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/molecular-and-cellular-neuroscience/ | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/YMCNE | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Academic Press Inc. | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1990 | ||||||||||||||||||||||||
每年文章數 | 68每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 33.33% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1044-7431%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Ordinary | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[MOLECULAR AND CELLULAR NEUROSCIENCE] 的評論 | 撰寫評論 |
作者: 逍遥英华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-09 20:25:08 評論於 Have you submitted this magazine in the end? How long after submitting did you receive the review notification? Thank you(0) 讚! | 逍遥英华 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:36:07 評論於 The number of corresponding authors for SCI journal articles is not necessarily limited to one, and there is no fixed standard. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only accept one corresponding author, if a paper lists multiple corresponding authors, the first corresponding author will be automatically selected. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. Other requirements follow the same logic. In other words, the number of authors listed as corresponding authors should comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiment and writing of the paper. They are the person who is listed first in the author list, but in collaborative work, it is common to have multiple first authors. There is no specific rule regarding the number of co-first authors, as it greatly depends on the workload, length of the paper, publication guidelines, and recognition by institutions. Generally, an SCI paper can have 2-4 first authors(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:06:42 評論於 Choose the journal from the same publisher that you want to transfer to, and submit your manuscript according to the submission guidelines of that journal(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 15:22:34 評論於 How many corresponding authors can there be at most? And how many first authors can there be at most?(0) 讚! | Darlene Pepys |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-25 21:00:57 評論於 How to transfer between different journals of the same publishing house?(0) 讚! | 修然小公主 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 18:15:08 評論於 3-point edge, hoping to maintain stability, a slight increase is also good(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us